i-KAIST Lab Co. Ltd. | Cash Flow

Fiscal year is January-December. All values KRW Millions.
2013
2014
2015
2016
2017
2018
Net Income before Extraordinaries
13,473
1,144
8,785
17,449
5,680
23,921
Depreciation, Depletion & Amortization
2,476
1,635
1,772
-
356
636
Other Funds
-
31
2
11,484
13,332
14,340
Funds from Operations
339
5,246
4,553
5,965
6,848
8,944
Changes in Working Capital
4,625
2,696
2,048
2,377
9,881
6,261
Net Operating Cash Flow
4,964
2,550
2,505
3,588
16,729
15,205
Capital Expenditures
2,353
1,612
875
371
398
Sale of Fixed Assets & Businesses
-
-
7
1,350
-
Purchase/Sale of Investments
1,744
1,453
305
1,605
6,735
Net Investing Cash Flow
3,835
159
1,463
938
8,521
Issuance/Reduction of Debt, Net
2,901
2,547
1,999
1,837
13,624
Net Financing Cash Flow
2,901
2,516
2,002
18,797
13,963
Net Change in Cash
1,770
127
1,965
14,271
12,156
Free Cash Flow
4,903
2,100
2,753
3,651
17,127
Deferred Taxes & Investment Tax Credit
898
3
4
-
-
-
Net Assets from Acquisitions
-
-
-
5,781
-
Other Sources
337
-
1,826
3,494
1,484
Change in Capital Stock
-
-
-
16,960
13,671
Exchange Rate Effect
1
1
1
-
869
Other Uses
74
-
2,115
1,234
2,873

About i-KAIST Lab Co.

View Profile
Address
27/F, Songdo Technopark IT Center
Inchon IN 21984
Korea, Republic Of
Employees -
Website http://www.gsinstrument.com
Updated 07/08/2019
POLUS BioPharm, Inc. engages in the manufacture and sale of electrical measuring, testing and analyzing instruments. Its main products include test and measuring instruments and telecommunication system. The test and measuring instruments consist of analyzer, analog oscilloscope, digital storage oscilloscope, generator, meter, counter, and power supply.